Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock Series A Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		1,250
Beginning balance at Dec. 31, 2023	$ 87,797	$ 0	$ 71	$ 365,591	$ 1	$ (277,866)
Beginning balance (in shares) at Dec. 31, 2023			70,691,992
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan (in shares)			91,969
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan	228			228
Stock-based compensation expense	1,968			1,968
Other comprehensive (loss) income	(20)				(20)
Net loss	(11,694)					(11,694)
Ending balance (in shares) at Mar. 31, 2024		1,250
Ending balance at Mar. 31, 2024	$ 78,279	$ 0	$ 71	367,787	(19)	(289,560)
Ending balance (in shares) at Mar. 31, 2024			70,783,961
Beginning balance (in shares) at Dec. 31, 2024	1,250	1,250
Beginning balance at Dec. 31, 2024	$ 68,226	$ 0	$ 71	372,489	(35)	(304,299)
Beginning balance (in shares) at Dec. 31, 2024	71,009,866		71,009,866
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan (in shares)			99,648
Issuance of common stock from exercise of stock options and purchases from employee stock purchase plan	$ 13			13
Stock-based compensation expense	1,284			1,284
Other comprehensive (loss) income	(12)				(12)
Net loss	$ (10,235)					(10,235)
Ending balance (in shares) at Mar. 31, 2025	1,250	1,250
Ending balance at Mar. 31, 2025	$ 59,276	$ 0	$ 71	$ 373,786	$ (47)	$ (314,533)
Ending balance (in shares) at Mar. 31, 2025	71,109,514		71,109,514